AUTHORS
Wimeth Dissanayake, BS, Yoko Mizoguchi, MD, PhD2, Tadashi Anan3, Kensaku Kohrogi4, Satoshi Okada, MD PhD5, Hirokazu Kanegane, MD, PhD6
AFFILIATIONS
1 Hiroshima University Hospital, Hiroshima, Hiroshima, Japan, NYU Langone, New York, New York, United States
2 Hiroshima University Hospital, Hiroshima, Hiroshima, Japan
3 Kumamoto University, Kumamoto, Japan
4 Kumamoto University, Kumamoto, Japan
5 Hiroshima University Hospital, Hiroshima, Hiroshima, Japan
6 Kumamoto University, Kumamoto, Japan
ABSTRACT
Background: Severe congenital neutropenias (SCN) are a group of disorders characterized by chronic neutrophil deficiency. They are most commonly caused by mutations in ELANE and HAX1, both acting through mechanisms that impair granulocyte progenitor survival and granulopoiesis via mitochondrial and secretory stress. During granulopoiesis, neutrophil progenitors are particularly susceptible to impairments in the secretory pathway, as they undergo a process of producing granules whose protein cargo undergo extensive proteolytic maturation and depend on ER chaperones. Recently, mutations in Hypoxia up-regulated 1 (HYOU1), a gene which encodes an ER-resident chaperone, were identified as a novel cause of SCN. Causative mutations occur at seven loci, affecting the signal peptide, ATPase, and peptide-binding domains of HYOU1. Here we focus on the homozygous L469P/L469P variant (HYOU1MUT/MUT) within the peptide-binding domain. This mutation was previously identified in a patient who showed downregulation of COPII-recruiting proteins, the complex mediating anterograde ER-to-Golgi transport, and also presented with B-cell deficiency and type I diabetes. Therefore, we suspected that HYOU1 dysfunction may disrupt trafficking through the early secretory pathway, specifically COPII-mediated ER-to-Golgi transport.
Methods: HYOU1MUT/MUT (L469P) variants were introduced into donor-derived iPS cells via CRISPR-Cas9 editing. Afterwards, iPSCs were differentiated through embryoid body formation into granulocytic progenitors (Cd11b+/Cd49d+) and mature neutrophils (Cd11b+/Cd49d-). Patient-derived peripheral blood neutrophils carrying the same L469P variant were purified via magnetic bead-based negative selection.
Results: To assess whether HYOU1 variants impair the formation of neutrophil secretory granules, immunofluorescence microscopy for the localization of the neutrophil granule cargo protein MPO was conducted. We found that in granulocytic progenitors MPO was observed to be retained within the ER of HYOU1MUT/MUT cells. This corresponded to mature HYOU1MUT/MUT neutrophils showing significantly fewer MPO+ granules than wild type cells. Given this impairment, we checked whether a corresponding functional defect was present via analysis of neutrophil extracellular trap (NET) formation. Immunofluorescence of NETosis showed reduced MPO incorporation into extracellular traps in both iPSC-derived and patient neutrophils. Further, ELISA showed reduced secretion of MMP9, another granule cargo protein, in HYOU1MUT/MUT neutrophils, indicating a general impairment in secretory granule formation. Next, to determine whether components of the COPII machinery may be underlying this impairment, the localization of key subunits was observed. Immunofluorescence microscopy showed that HYOU1MUT/MUT progenitors had reduced ER localization of Sec16a and Sec23b. Notably, in HYOU1MUT/MUT progenitors, Sec23b was found to be accumulated at the ER-Golgi intermediate compartment (ERGIC), instead of being actively recycled back to the ER membrane. We suspected that this mislocalization may cause slowed ER-Golgi trafficking, so Brefeldin A (BFA) recovery was assessed. HYOU1MUT/MUT progenitors showed resistance to cis-Golgi dissolution under BFA treatment, and slowed trans-Golgi recovery, indicating impaired anterograde transport.
Discussion: These results indicate that HYOU1MUT/MUT progenitors have a significant secretory defect, potentially caused by impaired ER export of secretory cargo. This is underlied by disrupted recruitment of the COPII coat at ER exit sites and altered ER-Golgi kinetics. The accumulation of COPII components at the ERGIC in progenitors suggests that HYOU1 mutations may delay recycling of COPII back to the ER or impair fusion of COPII vesicles with the ERGIC. Further work is required to decipher between these two mechanism, and how mutations in an ER chaperone may result in them.
DISCLOSURES
Wimeth Dissanayake, BS: No relevant conflicts of interest to declare.